Safety and efficacy of percutaneous intramyocardial bone marrow cell injection for chronic myocardial ischemia: Long ‐term results

ConclusionsThe present long‐term follow‐up study shows that intramyocardial BMC injection in patients with chronic myocardial ischemia is safe and improves both angina complaints and quality of life up to 5 years after BMC treatment.

Source: Journal of Interventional Cardiology - June 1, 2017 Category: Cardiology Authors: Sander F. Rodrigo, Imke Mann, Jan van Ramshorst, Saskia L. Beeres, Jaap Jan Zwaginga, Willem E. Fibbe, Jeroen J. Bax, Martin J. Schalij, Douwe E. Atsma Tags: ORIGINAL INVESTIGATION Source Type: research